hrp0086p1-p133 | Bone & Mineral Metabolism P1 | ESPE2016

Treatment with Zoledronic Acid in Children with Duchenne Muscular Dystrophy

Viseras Irene Fernandez , Konstantoulaki Ele , Jungbluth Heinz , Wraige Elizabeth , Gowda Vasantha , Hulse Tony , Cheung Moira

Background: Paediatric Osteoporosis can be a devastating complication of Duchenne muscular dystrophy (DMD). Treatment with intravenous bisphosphonates such as pamidronate is currently the first treatment choice for paediatric osteoporosis of different etiologies.Objective and hypotheses: The aims of our study were i) to identify the proportion of boys with DMD with osteoporosis in our service and ii) to evaluate the side-effect profile of those treated w...